These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 35069300)

  • 41. Gender differences of neurocognitive functioning in patients with first-episode schizophrenia in China.
    Pu C; Qiu Y; Zhou T; Yang F; Lu Z; Wang C; Deng H; Zhao J; Shi C; Yu X
    Compr Psychiatry; 2019 Nov; 95():152132. PubMed ID: 31669790
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognitive course in first-episode psychosis and clinical correlates: A 4 year longitudinal study using the MATRICS Consensus Cognitive Battery.
    Kenney J; Anderson-Schmidt H; Scanlon C; Arndt S; Scherz E; McInerney S; McFarland J; Byrne F; Ahmed M; Donohoe G; Hallahan B; McDonald C; Cannon DM
    Schizophr Res; 2015 Dec; 169(1-3):101-108. PubMed ID: 26416442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical Characteristics and Predictors of Outcome of Schizophrenia-Spectrum Psychosis in Children and Adolescents: A Systematic Review.
    Stentebjerg-Olesen M; Pagsberg AK; Fink-Jensen A; Correll CU; Jeppesen P
    J Child Adolesc Psychopharmacol; 2016 Jun; 26(5):410-27. PubMed ID: 27136403
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation Between Resting Theta Power and Cognitive Performance in Patients With Schizophrenia.
    Cao Y; Han C; Peng X; Su Z; Liu G; Xie Y; Zhang Y; Liu J; Zhang P; Dong W; Gao M; Sha S; Zhao X
    Front Hum Neurosci; 2022; 16():853994. PubMed ID: 35529780
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Profile of cognitive deficits and associations with depressive symptoms and intelligence in chronic early-onset schizophrenia patients.
    Jepsen JR; Fagerlund B; Pagsberg AK; Christensen AM; Nordentoft M; Mortensen EL
    Scand J Psychol; 2013 Oct; 54(5):363-70. PubMed ID: 23786210
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The trajectory of two negative symptom dimensions in first-episode psychosis and the role of cannabis use: A 10-year follow-up study.
    Ihler HM; Lyngstad SH; Gardsjord ES; Widing LH; Flaaten CB; Åsbø G; Wold KF; Engen MJ; Simonsen C; Ueland T; Lagerberg TV; Melle I; Romm KL
    Schizophr Res; 2023 Feb; 252():317-325. PubMed ID: 36706477
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Profile of cognitive deficits in schizophrenia and factor structure of the Czech MATRICS Consensus Cognitive Battery.
    Bezdicek O; Michalec J; Kališová L; Kufa T; Děchtěrenko F; Chlebovcová M; Havlík F; Green MF; Nuechterlein KH
    Schizophr Res; 2020 Apr; 218():85-92. PubMed ID: 32089475
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative study of clinical and neuropsychological characteristics between early-, late and very-late-onset schizophrenia-spectrum disorders.
    Hanssen M; van der Werf M; Verkaaik M; Arts B; Myin-Germeys I; van Os J; Verhey F; Köhler S;
    Am J Geriatr Psychiatry; 2015 Aug; 23(8):852-62. PubMed ID: 25500119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cognitive and Global Functioning in Patients With First-Episode Psychosis Stratified by Level of Negative Symptoms. A 10-Year Follow-Up Study.
    Engen MJ; Vaskinn A; Melle I; Færden A; Lyngstad SH; Flaaten CB; Widing LH; Wold KF; Åsbø G; Haatveit B; Simonsen C; Ueland T
    Front Psychiatry; 2022; 13():841057. PubMed ID: 35401286
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cognitive Profile in Ultra High Risk for Psychosis and Schizophrenia: A Comparison Using Coordinated Norms.
    Anda L; Brønnick KK; Johannessen JO; Joa I; Kroken RA; Johnsen E; Rettenbacher M; Fathian F; Løberg EM
    Front Psychiatry; 2019; 10():695. PubMed ID: 31632305
    [No Abstract]   [Full Text] [Related]  

  • 51. Dose reduction of risperidone and olanzapine can improve cognitive function and negative symptoms in stable schizophrenic patients: A single-blinded, 52-week, randomized controlled study.
    Zhou Y; Li G; Li D; Cui H; Ning Y
    J Psychopharmacol; 2018 May; 32(5):524-532. PubMed ID: 29493377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence, profile and associations of cognitive impairment in Ugandan first-episode psychosis patients.
    Mwesiga EK; Robbins R; Akena D; Koen N; Nakku J; Nakasujja N; Stein DJ
    Schizophr Res Cogn; 2022 Jun; 28():100234. PubMed ID: 35024348
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers.
    Stone WS; Mesholam-Gately RI; Giuliano AJ; Woodberry KA; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; McCarley RW; Heinssen R; Green MF; Nuechterlein K; Seidman LJ
    Schizophr Res; 2016 Apr; 172(1-3):106-13. PubMed ID: 26896388
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Large-scale evaluation of the Positive and Negative Syndrome Scale (PANSS) symptom architecture in schizophrenia.
    Lim K; Peh OH; Yang Z; Rekhi G; Rapisarda A; See YM; Rashid NAA; Ang MS; Lee SA; Sim K; Huang H; Lencz T; Lee J; Lam M
    Asian J Psychiatr; 2021 Aug; 62():102732. PubMed ID: 34118560
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Healthy Adolescent Performance With Standardized Scoring Tables for the MATRICS Consensus Cognitive Battery: A Multisite Study.
    Smelror RE; Jørgensen KN; Lonning V; Kelleher I; Cannon M; DeRosse P; Malhotra AK; Karlsgodt KH; Andreassen OA; Lundberg M; Edbom T; Cleland N; Ueland T; Myhre AM; Rund BR; Agartz I
    Schizophr Bull; 2019 Jun; 45(4):773-783. PubMed ID: 30239900
    [TBL] [Abstract][Full Text] [Related]  

  • 56. POSITIVE AND NEGATIVE SUBCLINICAL SYMPTOMS AND MCCB PERFORMANCE IN NON-PSYCHIATRIC CONTROLS.
    Korponay C; Nitzburg GC; Malhotra AK; DeRosse P
    Schizophr Res Cogn; 2014 Dec; 1(4):175-179. PubMed ID: 25530948
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Visual memory uniquely predicts anhedonia in schizophrenia but not bipolar disorder.
    Bodapati AS; Jenkins LM; Sharma RP; Rosen C
    J Neuropsychol; 2019 Mar; 13(1):136-146. PubMed ID: 28419772
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical and neurocognitive course in early-onset psychosis: a longitudinal study of adolescents with schizophrenia-spectrum disorders.
    Wozniak JR; Block EE; White T; Jensen JB; Schulz SC
    Early Interv Psychiatry; 2008 Aug; 2(3):169-77. PubMed ID: 21352150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Association Between Cognitive Deficits and Clinical Characteristic in First-Episode Drug Naïve Patients With Schizophrenia.
    Peng XJ; Hei GR; Yang Y; Liu CC; Xiao JM; Long YJ; Huang J; Zhao JP; Wu RR
    Front Psychiatry; 2021; 12():638773. PubMed ID: 33716832
    [No Abstract]   [Full Text] [Related]  

  • 60. Cognitive functioning in adolescents with schizophrenia treated with paliperidone extended-release: 6-Month exploratory analysis from an open-label, single-arm safety study.
    Pandina G; Nuamah I; Petersen T; Singh J; Savitz A; Hough D
    Schizophr Res Cogn; 2020 Jun; 20():100173. PubMed ID: 32154123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.